Skip to main content
Ethan Dmitrovsky, MD, Oncology, Lebanon, NH

Ethan Dmitrovsky MD

Oncology•Lebanon, NH

Professor, Pharmacology & Toxicology, Geisel School of Medicine

Join to View Full Profile

  • 1 Medical Center DrDhmc Department Of MedicineLebanon, NH 03756

  • Phone+1 603-650-6345

Dr. Dmitrovsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Dmitrovsky's Full ProfileAlready have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1983 - 1987
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1980 - 1983
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1980

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 1998 - 2026
  • TX State Medical License
    TX State Medical License 2016 - 2019
  • NY State Medical License
    NY State Medical License 1981 - 1999
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1994

Publications & Presentations

PubMed

Press Mentions

  • Ethan Dmitrovsky
    Ethan DmitrovskyJuly 28th, 2022
  • A Close Brush with Gun Violence Made Me Think About How to Confront an Epidemic During a Pandemic
    A Close Brush with Gun Violence Made Me Think About How to Confront an Epidemic During a PandemicAugust 1st, 2021
  • Lowy: “Our Patients Are Counting on Us, and We Must Not Let Them Down”
    Lowy: “Our Patients Are Counting on Us, and We Must Not Let Them Down”April 17th, 2020
  • Join now to see all

Grant Support

  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2029
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • LEIDOS FUNDING TO25, OPTION 1 MEASLESLEIDOS BIOMEDICAL RESEARCH, INC.2020–2028
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • CANCER MODELS FROM PEDIATRIC BRAIN AND SOLID CANCERS (CMDC)LEIDOS BIOMEDICAL RESEARCH, INC.2020–2027
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • FY22 - APA BUILDINGS - BUILDING 1LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).LEIDOS BIOMEDICAL RESEARCH, INC.2022–2026
  • ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENTLEIDOS BIOMEDICAL RESEARCH, INC.2021–2026
  • ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENTLEIDOS BIOMEDICAL RESEARCH, INC.2021–2026
  • ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENTLEIDOS BIOMEDICAL RESEARCH, INC.2021–2026
  • ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENTLEIDOS BIOMEDICAL RESEARCH, INC.2021–2026
  • ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENTLEIDOS BIOMEDICAL RESEARCH, INC.2021–2026
  • ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENTLEIDOS BIOMEDICAL RESEARCH, INC.2021–2026
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • AIDS AND CANCER VIRUS PROGRAMS (ACVP)LEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • NCI FY25 OPERATIONAL TASK ORDERLEIDOS BIOMEDICAL RESEARCH, INC.2024–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 - APA BUILDINGS - BUILDING 2LEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 Facilities Task Order B – Refurbishment and Infrastructure Projects focused on Facility Improvements within the NCI at Frederick CampusLEIDOS BIOMEDICAL RESEARCH, INC.2022–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • COORDINATING CENTER FOR THE NCI CERVICAL CANCER LAST MILE INITIATIVE SELF-SAMPLING FOR HPV TESTING TO IMPROVE CERVICAL CANCER PREVENTILEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • COORDINATING CENTER FOR THE NCI CERVICAL CANCER LAST MILE INITIATIVE SELF-SAMPLING FOR HPV TESTING TO IMPROVE CERVICAL CANCER PREVENTILEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • CORE SUPPORT FOR THE IMMUNE CELL NETWORKLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • FY22 CONSOLIDATED FACILITIES TASK ORDER CLEIDOS BIOMEDICAL RESEARCH, INC.2021–2025
  • DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25LEIDOS BIOMEDICAL RESEARCH, INC.2020–2025
  • Proteomic and Antibody Production and CharacterizationLEIDOS BIOMEDICAL RESEARCH, INC.2020–2025
  • DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25LEIDOS BIOMEDICAL RESEARCH, INC.2020–2025
  • DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2025
  • DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25LEIDOS BIOMEDICAL RESEARCH, INC.2020–2025
  • Proteomic and Antibody Production and CharacterizationLEIDOS BIOMEDICAL RESEARCH, INC.2020–2025
  • PREDICTIVE DRUG TESTING IN ORGANOID MODELSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2025
  • DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGSLEIDOS BIOMEDICAL RESEARCH, INC.2020–2025
  • DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25LEIDOS BIOMEDICAL RESEARCH, INC.2020–2025
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024
  • ENABLING NCI CLINICAL & RESEARCH DATA SHARINGLEIDOS BIOMEDICAL RESEARCH, INC.2021–2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Ethan Dmitrovsky, Dr. Ethan Dmitrovsky, MD, Dr. E Dmitrovsky